Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-16-100251
Filing Date
2016-05-10
Accepted
2016-05-10 11:14:29
Documents
2
Period of Report
2016-04-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A v439396_8k.htm 8-K/A 15522
2 EXHIBIT 10.1 v439396_ex10-1.htm EX-10.1 27152
  Complete submission text file 0001144204-16-100251.txt   44019
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35076 | Film No.: 161634280
SIC: 2835 In Vitro & In Vivo Diagnostic Substances